Actavis Net Revenue Increases 59% to $2.779 Billion in Fourth Quarter 2013LEARN MORE>
Actavis Net Revenue Increases 59% to $2.779 Billion in Fourth Quarter 2013
>Go!

Executive Officers and Directors

Executive Officers
Paul M. BisaroExecutive Chairman, Actavis plc
Brent L. SaundersCEO & President
Robert A. StewartChief Operating Officer
R.Todd JoyceChief Financial Officer – Global
David A. BuchenEVP, Commercial, North American Generics and International
Bill MeuryEVP, Commercial, North American Brands
Charles M. MayrChief Communications Officer – Global
Bob BaileyChief Legal Officer and Corporate Secretary
Directors
Paul M. BisaroExecutive Chairman, Actavis plc
Brent L. SaundersCEO & President, Actavis plc
Catherine  M.  KlemaLead Independent Director – President, Nettleton Advisors LLC
Nesli Basgoz, M.D.Associate Chief for Clinical Affairs, Division of Infectious Diseases, Massachusetts General Hospital (MGH)
James H. BloemSenior Vice President, Chief Financial Officer and Treasurer, Humana Inc.
Christopher W. BodineFormer President, Health Care Services for CVS Caremark Corporation
Christopher J. CoughlinFormer Executive Vice President and Chief Financial Officer, Tyco
Tamar D. HowsonFormer Member of JSB-Partners
John A. King, Ph.D.Former Executive Chairman, Galen Holdings Ltd
Jiri MichalFormer Chairman and Chief Executive Officer, Zentiva
Patrick J. O’SullivanFormer Chief Executive Officer, LEO Pharma Ireland
Ronald R. TaylorPresident, Tamarack Bay LLC
Andrew L. TurnerEnduracare Therapy Management, Inc.
Fred G. WeissManaging Director, FGW Associates, Inc.
ELECTRONIC ENROLLMENT